Scientists use nanoparticles to shut down mechanism that drives cancer growth

In a major step toward developing a novel therapy that targets epithelial?mesenchymal transition, scientists have inhibited the mechanism of the Twist protein using nanoparticles to deliver a nucleic acid called small interfering RNA, or siRNA, into tumor cells.